Sun Pharmaceutical Industries Ltd.

The December 2023 quarter revenue stood at Rs. 50737.50 millions, up 9.21% as compared to Rs. 46457.50 millions during the corresponding quarter last year.A comparatively good net profit growth of 48.20% to Rs. 7213.10 millions was reported for the quarter ended December 2023 compared to Rs. 4867.30 millions of previous same quarter.The company reported a good operating profit of 14358.00 millions compared to 10674.10 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202312	202212	% Var	202312	202212	% Var	202303	202203	% Var
Sales	50737.50	46457.50	9.21	146360.30	148639.20	-1.53	208121.40	155859.80	33.53
Other Income	2284.80	746.30	206.15	5079.50	2925.50	73.63	3292.90	11968.80	-72.49
PBIDT	14358.00	10674.10	34.51	40409.60	42709.40	-5.38	67518.90	38654.40	74.67
Interest	2149.20	1308.90	64.20	5664.90	3107.30	82.31	4721.80	3881.00	21.66
PBDT	11510.70	9365.20	22.91	32554.50	39602.10	-17.80	33419.20	16568.10	101.71
Depreciation	3996.00	4304.40	-7.16	12075.80	11888.90	1.57	16008.70	13499.50	18.59
PBT	7514.70	5060.80	48.49	20478.70	27713.20	-26.10	17410.50	3068.60	467.38
TAX	301.60	193.50	55.87	572.90	597.80	-4.17	503.30	4068.50	-87.63
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	7213.10	4867.30	48.20	19905.80	27115.40	-26.59	16907.20	-999.90	-1790.89
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	28.30	22.98	23.17	27.61	28.73	-3.91	32.44	24.80	30.81